Have a personal or library account? Click to login
Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes Cover

Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes

Romanian Journal of Internal Medicine
Volume 57 (2019): Issue 3 (September 2019)
By: Liudmyla G. Savchenko,  Nataliia I. Digtiar,  Liudmyla G. Selikhova,  Elvira I. Kaidasheva,  Oksana A. Shlykova,  Liudmyla E. Vesnina and  Igor P. Kaidashev  
Open Access
|Sep 2019
DOI: https://doi.org/10.2478/rjim-2019-0003 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 233 - 240
Submitted on: Sep 26, 2018
Published on: Sep 9, 2019
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
glucagon-like peptide 1 (GLP-1),
liraglutide,
diabetes,
obesity,
NF-kB,
SIRT1,
mediators of inflammation
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2019 Liudmyla G. Savchenko, Nataliia I. Digtiar, Liudmyla G. Selikhova, Elvira I. Kaidasheva, Oksana A. Shlykova, Liudmyla E. Vesnina, Igor P. Kaidashev, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 57 (2019): Issue 3 (September 2019)Next article